INMB
INmune Bio Inc
NASDAQ: INMB · HEALTHCARE · BIOTECHNOLOGY
$1.33
-5.00% today
Updated 2026-04-29
Market cap
$39.08M
P/E ratio
—
P/S ratio
781.61x
EPS (TTM)
$-1.86
Dividend yield
—
52W range
$1 – $8
Volume
0.4M
INmune Bio Inc (INMB) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $77.69M | $10916.00 | $181000.00 | $374000.00 | $155000.00 | $14000.00 | $50000.00 |
| Revenue growth (YoY) | — | — | — | — | — | -100.0% | +1558.1% | +106.6% | -58.6% | -91.0% | +257.1% |
| Cost of revenue | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | — | — | — | — |
| Gross profit | $0.00 | $0.00 | $0.00 | $0.00 | $77.69M | $10916.00 | $181000.00 | $374000.00 | $155000.00 | $14000.00 | $50000.00 |
| Gross margin | — | — | — | — | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| R&D | $101495.00 | $101495.00 | $435362.00 | $1.11M | $3.28M | $5.92M | $20.54M | $17.07M | $20.27M | $33.17M | $20.66M |
| SG&A | $195472.00 | $125996.00 | $546118.00 | $11.33M | $6.02M | $6.32M | $8.79M | $9.26M | $9.62M | $9.48M | $10.26M |
| Operating income | $-48868.00 | $-227000.00 | $-981000.00 | $-12.44M | $-7.76M | $-12.23M | $-29.15M | $-25.95M | $-29.74M | $-42.63M | $-30.87M |
| Operating margin | — | — | — | — | -10.0% | -112016.1% | -16106.6% | -6938.8% | -19187.7% | -304535.7% | -61738.0% |
| EBITDA | $146604.00 | $-50000.00 | $149990.00 | $-12.44M | $-7.68M | $-12.23M | $-30.34M | $-27.30M | $-29.74M | $-42.08M | $-30.79M |
| EBITDA margin | — | — | — | — | -9.9% | -112016.1% | -16762.4% | -7299.2% | -19187.7% | -300585.7% | -61570.0% |
| EBIT | $-48868.00 | $-277491.00 | $-831490.00 | $-12.44M | $-7.76M | $-12.23M | $-29.15M | $-25.95M | $-59.48M | $-42.63M | $-30.87M |
| Interest expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $1.19M | $1.35M | — | — | — |
| Income tax | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-48868.00 | $-277000.00 | $-831000.00 | $-12.44M | $-7.68M | $-12.10M | $-30.34M | $-28.65M | $-30.01M | $-42.08M | $-45.93M |
| Net income growth (YoY) | — | -466.8% | -200.0% | -1397.0% | +38.3% | -57.6% | -150.8% | +5.6% | -4.8% | -40.2% | -9.2% |
| Profit margin | — | — | — | — | -9.9% | -110838.8% | -16762.4% | -7659.6% | -19360.0% | -300585.7% | -91866.0% |